PMID: 11914179Mar 27, 2002Paper

Estrogen receptor beta in breast cancer

Endocrine-related Cancer
C PalmieriJ-A Gustafsson

Abstract

Estrogen is essential for normal growth and differentiation in the mammary gland. It also supports growth of approximately 50% of primary breast cancers. For this reason, removal of estrogen or blocking of its action with the anti-estrogen, tamoxifen, is the main treatment for estrogen receptor alpha (ERalpha)-positive tumors. In 1996, when oncologists became aware of a second ER, ERbeta, there was some doubt as to whether this receptor would be of importance in breast cancer because the clinical consensus was that responsiveness to tamoxifen is related to the presence of ERalpha in breast cancer. Today we know that ERalpha and ERbeta have distinct cellular distributions, regulate separate sets of genes and can oppose each other's actions on some genes. We also know that ERbeta is widely expressed in both the normal and malignant breast and that there are proliferating cells in the breast which express ERbeta. In this review we summarize what is known about ERbeta in breast cancer and examine the possibility that ERbeta-selective ligands may well represent a useful class of pharmacological tools with a novel target, namely proliferating cells expressing ERbeta.

Citations

Apr 4, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Rakesh Kumar
Feb 22, 2005·Bulletin of Experimental Biology and Medicine·L M BershteinV F Semiglazov
Apr 20, 2004·Critical Reviews in Oncology/hematology·Sandra Timm Pearce, V Craig Jordan
May 3, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Jochen ZimmermannErwin von Angerer
May 8, 2004·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M V Hofmeister, E C Bonefeld-Jørgensen
Sep 12, 2003·Trends in Pharmacological Sciences·Jan-Ake Gustafsson
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·C Kent Osborne, Rachel Schiff
Mar 9, 2004·The Lancet Oncology·Valerie SpeirsAndrew M Hanby
Apr 1, 2008·Animal : an International Journal of Animal Bioscience·J V NørgaardK Sejrsen
Aug 2, 2003·Breast Cancer Research and Treatment·Byeong-Woo ParkKyong Sik Lee
Nov 19, 2003·Breast Cancer Research and Treatment·Krista A Power, Lilian U Thompson
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maria Cristina AntalManuel Mark
Feb 22, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Young Choi, Marguerite Pinto
Feb 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D ChakravartyS Majumdar
Apr 29, 2004·Journal of Clinical Pathology·L NakopoulouA Keramopoulos
Mar 24, 2012·Molecular Cancer Therapeutics·Gangadhara R SareddyRatna K Vadlamudi
Mar 28, 2013·Endocrine-related Cancer·Etienne Leygue, Leigh C Murphy
Jun 23, 2010·Clinical Medicine Insights. Oncology·Pankaj TanejaKazushi Inoue
Jan 28, 2014·Breast Cancer Research and Treatment·Kevin C KnowerColin D Clyne
Dec 11, 2013·International Journal of Breast Cancer·Gerald M Higa, Ryan G Fell
Nov 7, 2013·Endocrine-related Cancer·Philip JonssonCecilia Williams
Sep 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Carola FörsterJan-Ake Gustafsson
Jan 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anders StrömJan-Ake Gustafsson
Feb 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Guojun ChengJan-Ake Gustafsson
Nov 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Carola FörsterJan-Ake Gustafsson
Apr 3, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Ludmila T Nogueira, Benedito B da Silva
Jul 2, 2005·Expert Opinion on Emerging Drugs·Shigehira Saji, Masakazu Toi
Jun 25, 2013·Drug Discovery Today. Disease Mechanisms·Monica M MontanoSmitha Sripathy
Feb 18, 2012·Pathology, Research and Practice·Kemal Kürşat Bozkurt, Nilgün Kapucuoğlu
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Doris Germain
Jun 30, 2009·Clinical Breast Cancer·Susan J CleatorCarlo Palmieri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.